Cargando…

Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data

OBJECTIVE: To identify the key individual-level (demographics, attitudes, mobility) and contextual (COVID-19 case numbers, tiers of mobility restrictions, urban districts) determinants of adopting the NHS COVID-19 contact tracing app and continued use overtime. DESIGN AND SETTING: A three-wave panel...

Descripción completa

Detalles Bibliográficos
Autores principales: Horvath, Laszlo, Banducci, Susan, Blamire, Joshua, Degnen, Cathrine, James, Oliver, Jones, Andrew, Stevens, Daniel, Tyler, Katharine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764714/
https://www.ncbi.nlm.nih.gov/pubmed/35039293
http://dx.doi.org/10.1136/bmjopen-2021-053327
_version_ 1784634222888091648
author Horvath, Laszlo
Banducci, Susan
Blamire, Joshua
Degnen, Cathrine
James, Oliver
Jones, Andrew
Stevens, Daniel
Tyler, Katharine
author_facet Horvath, Laszlo
Banducci, Susan
Blamire, Joshua
Degnen, Cathrine
James, Oliver
Jones, Andrew
Stevens, Daniel
Tyler, Katharine
author_sort Horvath, Laszlo
collection PubMed
description OBJECTIVE: To identify the key individual-level (demographics, attitudes, mobility) and contextual (COVID-19 case numbers, tiers of mobility restrictions, urban districts) determinants of adopting the NHS COVID-19 contact tracing app and continued use overtime. DESIGN AND SETTING: A three-wave panel survey conducted in England in July 2020 (background survey), November 2020 (first measure of app adoption) and March 2021 (continued use of app and new adopters) linked with official data. PARTICIPANTS: N=2500 adults living in England, representative of England’s population in terms of regional distribution, age and gender (2011 census). PRIMARY OUTCOME: Repeated measures of self-reported app usage. ANALYTICAL APPROACH: Multilevel logistic regression linking a range of individual level (from survey) and contextual (from linked data) determinants to app usage. RESULTS: We observe initial app uptake at 41%, 95% CI (0.39% to 0.43%), and a 12% drop-out rate by March 2021, 95% CI (0.10% to 0.14%). We also found that 7% of nonusers as of wave 2 became new adopters by wave 3, 95% CI (0.05% to 0.08%). Initial uptake (or failure to use) of the app associated with social norms, privacy concerns and misinformation about third-party data access, with those living in postal districts with restrictions on mobility less likely to use the app. Perceived lack of transparent evidence of effectiveness was associated with drop-out of use. In addition, those who trusted the government were more likely to adopt in wave 3 as new adopters. CONCLUSIONS: Successful uptake of the contact tracing app should be evaluated within the wider context of the UK Government’s response to the crisis. Trust in government is key to adoption of the app in wave 3 while continued use is linked to perceptions of transparent evidence. Providing clear information to address privacy concerns could increase uptake, however, the disparities in continued use among ethnic minority participants needs further investigation.
format Online
Article
Text
id pubmed-8764714
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87647142022-01-18 Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data Horvath, Laszlo Banducci, Susan Blamire, Joshua Degnen, Cathrine James, Oliver Jones, Andrew Stevens, Daniel Tyler, Katharine BMJ Open Public Health OBJECTIVE: To identify the key individual-level (demographics, attitudes, mobility) and contextual (COVID-19 case numbers, tiers of mobility restrictions, urban districts) determinants of adopting the NHS COVID-19 contact tracing app and continued use overtime. DESIGN AND SETTING: A three-wave panel survey conducted in England in July 2020 (background survey), November 2020 (first measure of app adoption) and March 2021 (continued use of app and new adopters) linked with official data. PARTICIPANTS: N=2500 adults living in England, representative of England’s population in terms of regional distribution, age and gender (2011 census). PRIMARY OUTCOME: Repeated measures of self-reported app usage. ANALYTICAL APPROACH: Multilevel logistic regression linking a range of individual level (from survey) and contextual (from linked data) determinants to app usage. RESULTS: We observe initial app uptake at 41%, 95% CI (0.39% to 0.43%), and a 12% drop-out rate by March 2021, 95% CI (0.10% to 0.14%). We also found that 7% of nonusers as of wave 2 became new adopters by wave 3, 95% CI (0.05% to 0.08%). Initial uptake (or failure to use) of the app associated with social norms, privacy concerns and misinformation about third-party data access, with those living in postal districts with restrictions on mobility less likely to use the app. Perceived lack of transparent evidence of effectiveness was associated with drop-out of use. In addition, those who trusted the government were more likely to adopt in wave 3 as new adopters. CONCLUSIONS: Successful uptake of the contact tracing app should be evaluated within the wider context of the UK Government’s response to the crisis. Trust in government is key to adoption of the app in wave 3 while continued use is linked to perceptions of transparent evidence. Providing clear information to address privacy concerns could increase uptake, however, the disparities in continued use among ethnic minority participants needs further investigation. BMJ Publishing Group 2022-01-17 /pmc/articles/PMC8764714/ /pubmed/35039293 http://dx.doi.org/10.1136/bmjopen-2021-053327 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Public Health
Horvath, Laszlo
Banducci, Susan
Blamire, Joshua
Degnen, Cathrine
James, Oliver
Jones, Andrew
Stevens, Daniel
Tyler, Katharine
Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title_full Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title_fullStr Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title_full_unstemmed Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title_short Adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
title_sort adoption and continued use of mobile contact tracing technology: multilevel explanations from a three-wave panel survey and linked data
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764714/
https://www.ncbi.nlm.nih.gov/pubmed/35039293
http://dx.doi.org/10.1136/bmjopen-2021-053327
work_keys_str_mv AT horvathlaszlo adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT banduccisusan adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT blamirejoshua adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT degnencathrine adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT jamesoliver adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT jonesandrew adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT stevensdaniel adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata
AT tylerkatharine adoptionandcontinueduseofmobilecontacttracingtechnologymultilevelexplanationsfromathreewavepanelsurveyandlinkeddata